¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myocardial metabolism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • myocardial anoxia
    ½É±Ù¹«»ê¼ÒÁõ, ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½É(Àå)±Ù(À°)¼öÃà·Â, ½É(Àå)±Ù(À°)¼öÃ༺
  • myocardial contraction
    ½É(Àå)±Ù(À°)¼öÃà
  • myocardial depressant factor
    ½É(Àå)±Ù(À°)¾ïÁ¦ÀÎÀÚ
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷, ½ÉÀå±ÙÀ°ÇãÇ÷
  • myocardial lead
    ½É±ÙÀ¯µµ, ½ÉÀå±ÙÀ°À¯µµ
  • myocardial perfusion scintigraphy
    ½É±Ù°ü·ù¼¶±¤Á¶¿µ(¼ú)
  • myocardial scan
    ½É±Ù½ºÄµ
  • metabolism
    ´ë»ç
  • microbial metabolism
    ¹Ì»ý¹°´ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myocardial contraction
    ½ÉÀå±ÙÀ°¼öÃà
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial depressant factor
    ½ÉÀå±Ù¾ïÁ¦ÀÎÀÚ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • transmural myocardial infarction
    ÀüÃþ½É±Ù°æ»öÁõ
  • myocardial lead
    ½É±ÙÀ¯µµ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • myocardial scan
    ½ÉÀå±ÙÀ°½ºÄµ
  • myocardial siderosis
    ½ÉÀå±ÙÀ°Ã¶Ä§ÂøÁõ
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phosphorus metabolism
    Àδë»ç(ìÝÓÛÞó)
  • product of metabolism
    ´ë»ç»ê¹°(ÓÛÞóß§Úª).
  • purine metabolism
    Ç»¸°´ë»ç(¡­ÓÛÞó).
  • purine metabolism
    Ç»¸°(Ǫ¸°)´ë»ç(¡­ÓÛÞó)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • drug metabolism
    ¾à¹°´ë»ç.
  • electrolyte metabolism
    ÀüÇØÁú´ë»ç(¡­ÓÛÞó).
  • energy metabolism
    ¿¡³ÊÁö´ë»ç.
  • energy metabolism
    ¿¡³ÊÁö´ë»ç(ÓÛÞó)
  • error of metabolism
    ´ë»ç(ÓÛÞó)ÀÌ»ó.
  • erythrocyte metabolism
    ÀûÇ÷±¸ ´ë»ç
  • exogenous metabolism
    ¿ÜÀμº ´ë»ç.
  • extrahepatic metabolism
    °£¿Ü´ë»ç(ÊÜèâÓÛÞó).
  • gaseous metabolism
    (È£Èí)°¡½º´ë»ç.
  • inborn error of metabolism
    ¼±Ãµ¼º ´ë»çÀÌ»ó(Áõ)(¡­ÓÛÞóì¶ßÈñø).
  • inborn error of metabolism
    ¼±Ãµ¼º´ë»çÀÌ»ó(à»ô¸àõÓÛÞóì¶ßÈ)
  • intermediary metabolism
    Áß°£´ë»ç.
  • intermediate metabolism
    Áß°£´ë»ç.
  • intermediate metabolism
    Áß°£´ë»ç(ñéÊàÓÛÞó).
  • iron metabolism
    ö´ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PMI pain management inventory; past medical illness; patient medication instruction; perioperative myoca...
SMI Self-Motivation Inventory; senior medical investigator; severe mental impairment; silent myocardial ...
TAMI thrombolysis and angioplasty in myocardial infarction; transmural anterior myocardial infarction
TIMI trhombolysis in myocardial infarction; transmural inferior myocardial infarction
TMI testing motor impairment; threatened myocardial infarction; transmural myocardial infarction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
"M" metabolism
AMI Acute Myocardial Infarction
AMI Acute myocardial infarct
AMI Anterior myocardial infarction
CK-MB Creatine kinase-myocardial band
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • arachidonic acid metabolism
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú
  • calcium metabolism
    Ä®½·´ë»ç
    Ç÷ÀåÁßÀÇ Ä®½· ³óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ¸ç »ÀÀÇ ¼®È¸È­¸¦ À§ÇÑ Ä®½· °ø±ÞÀ» ÇÏ´Â »ýÈ­ÇÐÀû, »ý¸®ÇÐÀû °úÁ¤.
  • calcium/phosphorus metabolism
    Ä®½·/ÀÎ ´ë»ç
  • carbohydrate metabolism disorder
    ź¼öÈ­¹° ´ë»ç Àå¾Ö
  • daily metabolism
    ÀÏÀÏ ¹°Áú ´ë»ç
  • drug metabolism
    ¾à¹° ´ë»ç
  • electrolyte metabolism
    ÀüÇØÁú ´ë»ç
  • energy metabolism
    ¿¡³ÊÁö ´ë»ç
  • iron metabolism
    ö ´ë»ç
    °¡ ÀÌ¿ÂÀÇ ÇüÅ·ΠÀ§ ¹× ½ÊÀÌÁöÀå »óºÎ¿¡¼­ Èí¼öµÈ öÀº ½ÊÀÌÁöÀå Á¡¸·ÀÇ ´Ü¹éÁú ¾ÆÆ÷Æä¸®Ä£°ú °áÇÕÇÏ¿© Æä¸®Ä£À¸·Î ÀúÀåµÈ´Ù. Ç÷Àå Áß¿¡ öÀÌ °¨¼ÒÇϸé Ç÷ÁßÀ¸·Î ȯ¿ø ö·Î¼­ ¹æÃâµÇ¾î Ç÷Àå Áß¿¡ Æ®·£½ºÆä¸°À̶ó°í Çϴ ƯÁ¤ÀÇ Ã¶ °áÇÕ¼º ´Ü¹é°ú °áÇÕÇÏ¿© À̵¿ÇÑ´Ù. ÀϺδ °£Àå, ºñÀåÀÇ ¸Á³»°è ¼¼Æ÷¿¡ ÀúÀåµÈ´Ù.
  • lipid metabolism
    ÁöÁú ´ë»ç
    °£¿¡¼­ ÈçÈ÷ ÀϾ¸ç Áö¹æ»êÀÇ º£Å¸-»êÈ­ ¹× ¾Æ¼¼Æ® ¾Æ¼¼Å×ÀÌÆ® Çü¼º, ´ç ÁöÁú »ý¼º, ÄÝ·¹½ºÅ×·Ñ ¹× ÀÎ ÁöÁú Çü¼º, ´ç°ú ´Ü¹éÁú·ÎºÎÅÍ Áö¹æÀÇ Àüȯ µîÀÌ °¡Àå ´ëÇ¥ÀûÀÌ´Ù.
  • lipoprotein metabolism disorer
    Áö´Ü¹é ´ë»ç Àå¾Ö
  • metabolism
    ´ë»ç, ¹°Áú ´ë»ç, ½ÅÁø´ë»ç
    »ì¾Æ ÀÖ´Â À¯±â ¹°ÁúÀ» ¸¸µé°í À¯ÁöÇÏ´Â °úÁ¤
  • metabolism disorder
    ´ë»ç Àå¾Ö
  • microbial metabolism
    ¹Ì»ý¹°ÀÇ ´ë»ç
  • mineral metabolism
    ±¤¹°Áú ´ë»ç, ¹«±âÁú ´ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
inborn errors of metabolism Term coined by A. Garrod in 1908 applying to heritable disorders of biochemistry. Examples include albinism, cystinuria (a cause of kidney stones) and phenylketonuria (pku) are a few of the hundreds of inborn errors of metabolism.
(12 Dec 1998)
intermediary metabolism Enzyme-catalysed processeswithin cells that extract energy from nutrientmolecules and use that energy to construct cellular components.
(09 Oct 1997)
iron metabolism disorders Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
oxidative metabolism Respiration in the biochemical sense.
(18 Nov 1997)
electrolyte metabolism The chemical changes that various essential minerals (e.g., sodium, potassium, calcium, magnesium) undergo in the tissues.
(05 Mar 2000)
energy metabolism Those metabolic reactions whose role is to release or to provide energy.
(05 Mar 2000)
fat metabolism Oxidation, decomposition, and synthesis of fats in the tissues.
(05 Mar 2000)
fructose metabolism, inborn errors Inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency (essential fructosuria), hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. Essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosaemia, but with no clinical dysfunction; may produce a false-positive diabetes test.
(12 Dec 1998)
anterior myocardial infarction Infarction involving the anterior wall of the heart, and producing indicative electrocardiographic changes in the anterior chest leads and often in limb lead I.
(05 Mar 2000)
anteroinferior myocardial infarction Infarction involving both anterior and inferior walls of the heart simultaneously.
(05 Mar 2000)
anterolateral myocardial infarction Extensive anterior infarction producing indicative changes across the precordium as well as in leads I and aVL.
(05 Mar 2000)
anteroseptal myocardial infarction An anterior infarction in which indicative electrocardiographic changes are confined to the medial chest leads (V1-V4).
(05 Mar 2000)
biopsy, myocardial <investigation, procedure, surgery> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck).
This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(21 Mar 1998)
myocardial Refers to the heart's muscle mass.
(09 Oct 1997)
myocardial biopsy <procedure> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á